1. Rochelle, R., C., Othávio, P., B., Pedro, F., Flávio, A., Castro (2018). Sampling procedures and calculation for sample size determination: criteria and methods adopted in theses and dissertations in Human Movement Sciences - a descriptive study. Retrieved online https://doi.org/10.5007/1980-0037.2018v20n5p480 [12-oct-2020]
2. Rensburg, V., R., Reuter, H. (2019). An overview of analgesics: NSAIDs, paracetamol, and topical analgesics Part 1: South African Family Practice, 61:sup1, S4-S10, retrieved online <DOI: 10.1080/20786190.2019.1610228> [23-December-2019]
3. Amol, B., D, Jayprabha, R., Dhumane, Hrushikesh, V., Wagh, Rushikesh, B., S. (2019). Asian Journal of Pharmaceutical Research and Development: Open Access to Pharmaceutical and Medical Research. Retrieved online <15.12.2019 at http://ajprd.com> [March-17-2020]
4. Jaycharan, C., Tamoghna, B. (2013). How to calculate sample size for different study designs in medical research? Indian Journal of medical research. Retrieved online [December-20-2016]
5. Laura, J., Hunter, Wood, M., D., Dargan, P., I. (2011). The patterns of toxicity and management of acute nonsteroidal anti-inflammatory drug (NSAID) overdose: Dove press journal. Retrieved online <http://dx.doi.org/10.2147/OAEM.S22795> [June-3-2019]
6. Centre for disease control and prevention [CDC] (2019). Viral Hemorrhagic Fevers. Fact sheet. Retrieved online [27-March-2019]
7. Amol, B., D, Jayprabha, R., Dhumane, Hrushikesh, V., Wagh, Rushikesh, B., S. (2019). The Stages of Drug Discovery and Development Process; Asian Journal of Pharmaceutical Research and Development: Retrieved online <15.12.2019 at http://ajprd.com> [March-10-2019]
8. Cotran, R., S., Kumar, V., Collins, T. (2012). Robins pathologic basis of diseases. J.B.Saunders Company Philadilphia, 6th edition
9. Dey, N., C., Dey, T., K. (2014). A Textbook of Pathology Calcatta, Messers Allied agency 10th edition 2014
10. Gashaw, I., Ellinghaus, P., Sommer, A., Asadullah, K. (2012). What makes a good drug target. Drug Discovery Today, 17:S24-S30.
11. Karara, A., H., Edeki, T., McLeod, J. (2010). PhRMA survey on the conduct of first-in-human clinical trials under exploratory investigational new drug applications. Journal of ClinicalPharmacology, 50:380– 391.
12. Moffat, J., Vincent, F., Lee, J., Eder, J., Prunotto, M. (2017). Opportunities and challenges in phenotypic drug discovery: an industry perspective. Nature Reviews Drug Discovery, 16(8):531-543
13. Patidar, A., K., Selvam, G., Jeyakandan, M., Mobiya, A., K., Bagherwal, A., Sanadya, G., Mehta, R. (2011). Lead Discovery and lead optimization: A useful strategy in molecular modification of lead compound in analog design. International journal of drug design and discovery. 2(2):458- 463.
14. Winge, D., R. (2012). Principles of molecular biology. 32(14): 2647–2652 Retrieved onloine <doi: 10.1128/MCB.00573-12> [12-12-2020]
No comments:
Post a Comment